ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in June:
Jefferies Global Healthcare Conference – Participating in a fireside chat on Wednesday, June 4, 2025, at 12:50 p.m. ET
Goldman Sachs 46th Annual Global Healthcare Conference – Participating in a fireside chat on Tuesday, June 10, 2025, at 10:00 a.m. ET
Webcasts of the discussions will be available through the investor section of the company's website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
Contact:Dominic Piscitelli, Chief Financial Officerdominic.piscitelli@oricpharma.cominfo@oricpharma.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
A Once-in-a-Decade Opportunity: 1 Super Growth Stock Down 48% to Buy Right Now and Hold for a Decade
Shares of software-as-a-service platform Nice remain nearly 50% below their 2021 highs. However, the company's leading position and burgeoning AI sales point to a promising future ahead. With its valuation near a decade low, Nice is buying back shares -- and investors should consider them too. 10 stocks we like better than Nice › While buying a roughed-up stock "on the dip" seems like a no-brainer, the unfortunate truth is that many of these embattled businesses may actually prove to be "falling knives." However, if investors prioritize high-quality, market-leading, innovative companies, buying the dip can occasionally make perfect sense. I'd argue this is especially true when the stock in question is trading at what appears to be a once-in-a-decade valuation, which is the case for the business we will examine today. Operating in three industry verticals buoyed by long-term megatrends, Nice (NASDAQ: NICE) and its artificial intelligence (AI) innovations could prove to be an excellent buy-the-dip candidate, especially since its stock is down 48% from its highs. Nice is a leading software-as-a-service (SaaS) business, providing AI-powered solutions to enterprises via its cloud platform. The company primarily serves three areas: Customer engagement (About 75% of sales): Nice offers end-to-end SaaS solutions that help clients automate their customer service operations while augmenting their human workforce with agentic AI. The cornerstone of this effort is its center-as-a-service (CCaaS) platform, which Forrester ranks as one of the leaders in this niche. Financial crime and compliance (15% of sales): Nice's AI-embedded tools help corporate customers battle fraud, money laundering, and suspicious activity while providing compliance and surveillance services. It uses machine learning to parse through mountains of financial data and AI to automate more mundane tasks. Many top U.S. and European banks use this service. Public safety and justice (10% of sales): In its smallest segment, Nice helps with emergency response optimization and digital evidence management. Nice and Axon Enterprise are the two leaders in this niche, according to IDC, acting like the Coca-Cola and PepsiCo to the public safety and justice market. Nice's offerings are used by 85% of U.S. and Canadian cities and 94% of the United Kingdom's police stations. Thanks to its leadership in these three niches -- and counting 85 of the Fortune 100 enterprises as customers -- Nice is an undeniable SaaS leader with sales in over 150 countries. Yet, despite this powerful presence, the company's growth story could still be in its early chapters. With fraud and money laundering schemes increasing in complexity by the day, digital evidence growing exponentially, and AI providing a tailwind in each market, Nice could be positioned for decades of growth if it can successfully harness the power of AI. Far and away, the most important thing for investors to watch going forward with Nice will be whether it remains an AI innovator, not a disruptee. The company is off to a tremendous start so far, with AI solutions at the forefront of its platform. In 2024, 97% of Nice's CXone Mpower contracts worth $1 million or more included AI offerings. This figure grew to 100% as of the first quarter of 2025, demonstrating that the company is, if nothing else, AI-first. Furthermore, while overall cloud revenue grew 12% in Q1, Nice's AI and self-service sales grew by 39%. This data point will be paramount to watch going forward, as this outsize growth suggests that Nice is leading the AI innovation race, rather than getting disrupted by it. Similarly, its cloud net retention rate of 111% highlights additional customer "buy-in." Measuring the spending of existing customers from last year to this year, this 11% increase indicates that the company is successfully upselling and cross-selling its new solutions, most likely AI-powered offerings. Despite reporting top-notch AI sales growth, Nice's shares slid following its Q1 earnings, mainly due to what the market deemed weak guidance. This drop leaves the company trading at just 14 times free cash flow (FCF). This price-to-FCF (P/FCF) ratio of 14 is near a decade-long low and is almost half of the company's historical average of 27. Even accounting for the dilutive effects of stock-based compensation, Nice trades at just 18 times FCF, far below the S&P 500's average P/FCF ratio, which is somewhere north of 30. Perhaps the biggest signal that Nice's valuation today may be a once-in-a-decade opportunity comes from management currently buying back shares at the fastest rate in the company's history. Nice is armed with more than $1 billion in net cash, compared to its market capitalization of $11 billion, so it could easily continue buying back shares at what looks like an incredible valuation. Altogether, Nice's combination of leadership positioning, AI integration, and discounted valuation makes it a super growth stock to buy on the dip. However, it'll be of the utmost importance to keep an eye on Nice's AI sales in each quarterly update and ensure the company remains the AI innovator, not the disruptee. Before you buy stock in Nice, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nice wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Josh Kohn-Lindquist has positions in Axon Enterprise and Coca-Cola. The Motley Fool has positions in and recommends Amazon, Axon Enterprise, and Nice. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy. A Once-in-a-Decade Opportunity: 1 Super Growth Stock Down 48% to Buy Right Now and Hold for a Decade was originally published by The Motley Fool
Yahoo
27 minutes ago
- Yahoo
'I Bought Netflix At $12 And Sold At $10. Now It's At $1,100, Says Scott Galloway, Hates When People Only Post Their Wins Online
Scott Galloway, the outspoken professor and entrepreneur, says he gets it wrong all the time—and he doesn't try to hide it. 'I bought Netflix at $12 and sold it at $10. Now it's at $1,100,' he said on a recent episode of the 'My First Million' podcast. 'I can't stand people who are constantly taking pictures of all their wins and posting them on social.' Despite that Netflix (NASDAQ:NFLX) miss, Galloway has racked up some big wins, mostly by betting on unpopular, overlooked assets. He says the best returns don't come from trendy stocks, but from distressed situations that smell, as he put it, 'like urine.' Don't Miss: Invest where it hurts — and help millions heal:.One of his best trades? Buying $10 million in FTX bankruptcy claims for $2.2 million after digging through the exchange's filings. He figured their investment in AI company Anthropic was worth much more than creditors realized. "Crypto took off, everything they had invested in went crazy," he said. 'Looks like we're going to get 160 cents on the dollar.' He admits there was risk, but also effort. 'I'm that guy who reads bankruptcy filings,' he said. Galloway's biggest return came from helping bring vape company NJOY out of bankruptcy. He initially put in $2.5 million. After the company received the U.S. Food and Drug Administration approval and was bought by Altria (NYSE:MO), his stake turned into $75 million. 'We almost went to zero two or three times,' he said. 'But that was hands down my best investment.' Trending: Another win came from dying yellow pages company Dex Media. He got in for about $4 million and sold after the business successfully pivoted into software. "What is less sexy than Yellow Pages?" he said. Still, he doesn't shy away from his losses. He once invested $5 million in a healthcare texting company that went to zero in just 18 months. And he left $2 million on the table after selling covered calls on a stock that jumped right after earnings. Galloway is now moving away from U.S. equities, citing sky-high valuations and political instability. "[If] you think you're diversified because you're in an index fund, you're not, because I believe the U.S. is going to go flat in the next decade," he said. 'I'm going to be almost entirely out of the U.S. market within three or four months.' He's especially bullish on Europe, clarifying how everyone thinks Europe is overregulated and boring, but that's exactly when you invest. 'When something's been left for dead,' he said. Read Next: These five entrepreneurs are worth $223 billion – Here's what Americans think you need to be considered 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? NETFLIX (NFLX): Free Stock Analysis Report ALTRIA GROUP (MO): Free Stock Analysis Report This article 'I Bought Netflix At $12 And Sold At $10. Now It's At $1,100, Says Scott Galloway, Hates When People Only Post Their Wins Online originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
Aviation Analyst: SpaceX Starship grounded after third test flight explosion
CHARLOTTE () — Another blow for Elon Musk's SpaceX. Its giant Starship is grounded yet again after exploding during another test flight, the third time this year. Chief transportation correspondent MayCay Beeler explains what went into the decision. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
